New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
09:11 EDTRHHBY, DDD, XONE, PRGO, ARUN, SNY, SSYS, PLUG, KBIO, SUPN, NDLS, ITMN, VJET, KSS, VIPS, ENPHOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Kohl's (KSS), up 2.5%... Plug Power (PLUG), up 10%... Perrigo (PRGO), up 4.5%. HIGHER: Aruba Networks (ARUN), up 3% after shares upgraded at Stifel... KaloBios (KBIO), up 7.9% after publication shows EphA3 as target for anticancer therapy... Supernus (SUPN), up 4.4% after receiving FDA fast track designation for SPN-810. DOWN AFTER EARNINGS: Noodles & Company (NDLS), down 22%... Vipshop (VIPS), down 5.8%. LOWER: ExOne (XONE), down 10.7%, Voxeljet (VJET), down 6.6%, after earnings reports. Peers in the 3D space are lower as well, with Stratasys (SSYS) down 1% and 3D Systems (DDD) down 0.2%... Enphase Energy (ENPH), down 2.6% after filing to sell common stock for holders... InterMune (ITMN), down 3% after downgraded at Goldman following yesterday's advance on Bloomberg report that the company received takeover bids from Sanofi (SNY), Roche (RHHBY).
News For KSS;PLUG;XONE;VJET;SSYS;DDD;ITMN;SNY;RHHBY;NDLS;ARUN;ENPH;SUPN;PRGO;VIPS;KBIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
April 16, 2015
11:04 EDTENPHEnphase Energy initiated with an Outperform at Avondale
Target $18.
10:15 EDTPRGOOptions with decreasing implied volatility
Subscribe for More Information
08:04 EDTRHHBYRoche granted orphan status for lymphoma treatment
The FDA granted Roche's Genentech unit orphan status for Gazyva, its treatment of follicular lymphoma.
April 15, 2015
12:18 EDTPLUGPlug Power CEO bullish on improving sales process, blogger says
Following a tour of Plug Power's Latham facility, financial blogger Jennifer Galperin said company CEO Andy Marsh is keenly aware of criticisms, particularly those focused on meeting or exceeding guidance. Marsh seems very bullish on PLUG's ability to move more big customers to a type of sales process that is more of a planning process where there is longer-term clarity, according to the post by Galperin that was featured on the blog of investor and a trader Michael Bigger. Reference Link
11:56 EDTSNYSanofi initiated with a Buy at Societe Generale
Subscribe for More Information
10:00 EDTENPHOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:02 EDTPRGORBC sees Akorn as possible play on Perrigo takeover interest
Subscribe for More Information
07:41 EDTSNYEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
07:30 EDTSSYSStratasys price target lowered to $82 from $100 at Canaccord
Canaccord lowered its price target on Stratasys to $82 from $100 to reflect a more back-end loaded year driven by lengthening sales cycles at resellers, a challenging integration effort for digital manufacturing, and a less likely imminent recovery for MakerBot. Canaccord maintains its Buy rating on Stratasys.
06:21 EDTENPHEnphase Energy initiated with an Overweight at JPMorgan
JPMorgan started shares of Enphase Energy with an Overweight rating saying the company offers pure-play exposure to the "rapid growth" in residential rooftop solar through 2016. The firm put a $16 price target on the shares.
06:09 EDTPRGOStocks with implied volatility below IV index mean; FXE PRGO
Subscribe for More Information
April 14, 2015
10:50 EDTPRGOOptions with increasing implied volatility
Subscribe for More Information
09:37 EDTPLUGPlug Power says FedEx rolling out GenDrive powered cargo tuggers
Subscribe for More Information
06:30 EDTRHHBYRoche to seek to have cancer drug tested in 11 trials in 2015, Reuters says
Roche said it would seek to have its immunotherapy cancer drug, MPDL3280A, in 11 late stage trials by the end of 2015, aaccording to Reuters. The drug is being tested in melanoma, as well as lung, bladder, kidney, bowel and blood cancers, the news service noted. Reference Link
April 13, 2015
10:48 EDTPRGOOptions with increasing implied volatility
Options with increasing implied volatility: CLDN WETF EWH FOSL FXI TLM PRGO ATHN SYMC MAC
10:01 EDTRHHBYRoche acquires CAPP Medical
Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA in blood.
08:17 EDTARUNAruba Networks selected by Boston Medical Center for app solutions
Aruba Networks announced that Boston Medical Center, a private, not-for-profit, 482-bed, academic medical center in Boston, MA., is deploying Aruba’s 802.11ac and mobile app solutions to enable a campus-wide Gigabit wireless network with indoor location services that will benefit physicians, staff and patients.
07:56 EDTPRGOMylan, Teva, Perrigo price targets raised at JPMorgan
Subscribe for More Information
06:49 EDTPRGOMylan notifies Perrigo of HSR filing regarding proposed acquisition
Mylan N.V. (MYL) announced that it has provided Perrigo (PRGO) with notice of its filing of the premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with the U.S. Federal Trade Commission and the U.S. Department of Justice Antitrust Division regarding its proposed acquisition of Perrigo, as required by the HSR Act. Mylan proposed to acquire Perrigo for $205 per share in a cash-and-stock transaction on April 6.
06:00 EDTDDDStocks with implied volatility above IV index mean; DDD HOT
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use